1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Landis MD, Lehmann BD, Pietenpol JA and
Chang JC: Patient-derived breast tumor xenografts facilitating
personalized cancer therapy. Breast Cancer Res. 15:2012013.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Hulka BS and Moorman PG: Breast cancer:
Hormones and other risk factors. Maturitas. 38:103–116. 2001.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Moore NM and Nagahara LA: Physical biology
in cancer. 1. Cellular physics of cancer metastasis. Am J Physiol
Cell Physiol. 306:C78–C79. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Osborne CK and Schiff R: Estrogen-receptor
biology: Continuing progress and therapeutic implications. J Clin
Oncol. 23:1616–1622. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Doisneau-Sixou SF, Sergio CM, Carroll JS,
Hui R, Musgrove EA and Sutherland RL: Estrogen and antiestrogen
regulation of cell cycle progression in breast cancer cells. Endocr
Relat Cancer. 10:179–186. 2003. View Article : Google Scholar : PubMed/NCBI
|
7
|
Cunliffe HE, Ringnér M, Bilke S, Walker
RL, Cheung JM, Chen Y and Meltzer PS: The gene expression response
of breast cancer to growth regulators: Patterns and correlation
with tumor expression profiles. Cancer Res. 63:7158–7166.
2003.PubMed/NCBI
|
8
|
Basu A and Rowan BG: Genes related to
estrogen action in reproduction and breast cancer. Front Biosci.
10:2346–2372. 2005. View
Article : Google Scholar : PubMed/NCBI
|
9
|
Deroo BJ and Korach KS: Estrogen receptors
and human disease. J Clin Invest. 116:561–570. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Yager JD and Davidson NE: Estrogen
carcinogenesis in breast cancer. N Engl J Med. 354:270–282. 2006.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhao Z, Chen C, Liu Y and Wu C:
17β-Estradiol treatment inhibits breast cell proliferation,
migration and invasion by decreasing MALAT-1 RNA level. Biochem
Biophys Res Commun. 445:388–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lamb R, Lehn S, Rogerson L, Clarke RB and
Landberg G: Cell cycle regulators cyclin D1 and CDK4/6 have
estrogen receptor-dependent divergent functions in breast cancer
migration and stem cell-like activity. Cell Cycle. 12:2384–2394.
2013. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Miyoshi Y, Murase K, Saito M, Imamura M
and Oh K: Mechanisms of estrogen receptor-α upregulation in breast
cancers. Med Mol Morphol. 43:193–196. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Tyson JJ, Baumann WT, Chen C, Verdugo A,
Tavassoly I, Wang Y, Weiner LM and Clarke R: Dynamic modelling of
oestrogen signalling and cell fate in breast cancer cells. Nat Rev
Cancer. 11:523–532. 2011. View
Article : Google Scholar : PubMed/NCBI
|
17
|
Berger CE, Qian Y, Liu G, Chen H and Chen
X: p53, a target of estrogen receptor (ER) α, modulates DNA
damage-induced growth suppression in ER-positive breast cancer
cells. J Biol Chem. 287:30117–30127. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Platet N, Cathiard AM, Gleizes M and
Garcia M: Estrogens and their receptors in breast cancer
progression: A dual role in cancer proliferation and invasion. Crit
Rev Oncol Hematol. 51:55–67. 2004. View Article : Google Scholar : PubMed/NCBI
|
19
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|